Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
41.20%
median of 862 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Revelation Biosciences, Inc.
Market Cap
$2.94M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$2.86M
Gross Margin
36.10%
TTM Avg
40.19%
3Y Avg
41.87%
5Y Avg
47.28%
Market Cap
$3.07M
Gross Margin
0.00%
TTM Avg
-310.04%
3Y Avg
-329.59%
5Y Avg
-274.54%
Market Cap
$3.14M
Gross Margin
92.09%
TTM Avg
93.19%
3Y Avg
96.59%
5Y Avg
97.73%
Market Cap
$3.21M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
25.00%
5Y Avg
50.00%
Market Cap
$2.66M
Gross Margin
35.28%
TTM Avg
30.83%
3Y Avg
37.03%
5Y Avg
41.13%
Market Cap
$3.28M
Gross Margin
16.54%
TTM Avg
-251.00%
3Y Avg
-125.05%
5Y Avg
-78.44%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Revelation Biosciences, Inc. (REVB) | $2.94M | 0.00% | 0.00% | 0.00% | 0.00% |
| IceCure Medical Ltd (ICCM)vs › | $2.86M | 36.10% | 40.19% | 41.87% | 47.28% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.07M | 0.00% | -310.04% | -329.59% | -274.54% |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.14M | 92.09% | 93.19% | 96.59% | 97.73% |
| iSpecimen Inc. (ISPC)vs › | $2.69M | 1.25% | 22.09% | 37.48% | 43.16% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.21M | 0.00% | 0.00% | 25.00% | 50.00% |
| Universe Pharmaceuticals Inc. (UPC)vs › | $2.66M | 35.28% | 30.83% | 37.03% | 41.13% |
| MBody AI Ltd. (MBAI)vs › | $3.25M | 0.00% | 0.00% | 0.00% | 0.00% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.28M | 16.54% | -251.00% | -125.05% | -78.44% |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | 79.65% | 78.98% | 76.82% | 80.07% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
